{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:13:06Z","timestamp":1747973586955,"version":"3.41.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,22]]},"DOI":"10.7759\/cureus.84616","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T14:26:36Z","timestamp":1747923996000},"source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Options for the Prevention of Thromboses in Cushing\u2019s Syndrome: A Propensity-Matched, Retrospective Cohort Analysis"],"prefix":"10.7759","author":[{"given":"Maxim J","family":"Barnett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Eidbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00070.2006","article-title":"Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner","volume":"291","author":"Ulrich-Lai YM","year":"2006","unstructured":"Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab. 2006, 291:E965-73. 10.1152\/ajpendo.00070.2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1023\/a:1009905808033","article-title":"Cushing's syndrome: historical aspects","volume":"3","author":"Lindholm J","year":"2000","unstructured":"Lindholm J. Cushing's syndrome: historical aspects. Pituitary. 2000, 3:97-104. 10.1023\/a:1009905808033","journal-title":"Pituitary"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2014.282871","article-title":"Cushing's syndrome: from physiological principles to diagnosis and clinical care","volume":"593","author":"Raff H","year":"2015","unstructured":"Raff H, Carroll T. Cushing's syndrome: from physiological principles to diagnosis and clinical care. J Physiol. 2015, 593:493-506. 10.1113\/jphysiol.2014.282871","journal-title":"J Physiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome","volume":"367","author":"Newell-Price J","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing\u2019s syndrome. Lancet. 2006, 367:1605-17. 10.1016\/S0140-6736(06)68699-6","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac492","article-title":"Approach to the patient: diagnosis of Cushing syndrome","volume":"107","author":"Savas M","year":"2022","unstructured":"Savas M, Mehta S, Agrawal N, van Rossum EF, Feelders RA. Approach to the patient: diagnosis of Cushing syndrome. J Clin Endocrinol Metab. 2022, 107:3162-74. 10.1210\/clinem\/dgac492","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvz033","article-title":"Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study","volume":"4","author":"Suarez MG","year":"2020","unstructured":"Suarez MG, Stack M, Hinojosa-Amaya JM, et al.. Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study. J Endocr Soc. 2020, 4:bvz033. 10.1210\/jendso\/bvz033","journal-title":"J Endocr Soc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101496","article-title":"Hypercoagulability in Cushing's syndrome: from arterial to venous disease","volume":"35","author":"St-Jean M","year":"2021","unstructured":"St-Jean M, Lim DS, Langlois F. Hypercoagulability in Cushing's syndrome: from arterial to venous disease. Best Pract Res Clin Endocrinol Metab. 2021, 35:101496. 10.1016\/j.beem.2021.101496","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman LK","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A. Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015, 100:2807-31. 10.1210\/jc.2015-1818","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf017","article-title":"Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statement","volume":"192","author":"Isand K","year":"2025","unstructured":"Isand K, Arima H, Bertherat J, et al.. Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statement. Eur J Endocrinol. 2025, 192:R17-27. 10.1093\/ejendo\/lvaf017","journal-title":"Eur J Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.inat.2021.101371","article-title":"Venous thromboembolic (VTE) prophylaxis in Cushing Disease patients undergoing transsphenoidal surgery","volume":"27","author":"McCormick JP","year":"2022","unstructured":"McCormick JP, Sun M, Shafqat I, Heaney AP, Bergsneider M, Wang MB. Venous thromboembolic (VTE) prophylaxis in Cushing Disease patients undergoing transsphenoidal surgery. Interdiscip Neurosurg. 2022, 27:10.1016\/j.inat.2021.101371","journal-title":"Interdiscip Neurosurg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01261-9","article-title":"Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols","volume":"25","author":"Feelders RA","year":"2022","unstructured":"Feelders RA, Nieman LK. Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols. Pituitary. 2022, 25:746-9. 10.1007\/s11102-022-01261-9","journal-title":"Pituitary"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1309","article-title":"Management of endocrine disease: cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing\u2019s syndrome: a practical approach","volume":"184","author":"Varlamov EV","year":"2021","unstructured":"Varlamov EV, Langlois F, Vila G, Fleseriu M. Management of endocrine disease: cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing\u2019s syndrome: a practical approach. Eur J Endocrinol. 2021, 184:R207-24. 10.1530\/EJE-20-1309","journal-title":"Eur J Endocrinol"},{"key":"ref13","article-title":"Hypercoagulability in Cushing\u2019s disease: a risk awareness and prophylaxis survey on behalf of the Pituitary Society","author":"Fleseriu M","year":"2017","unstructured":"Fleseriu M, Biller BM, Grossman A, Swearingen B, Melmed S. Hypercoagulability in Cushing\u2019s disease: a risk awareness and prophylaxis survey on behalf of the Pituitary Society. 15th International Pituitary Congress: Program and Abstracts. The Pituitary Society, Orlando, FL; 2017. 35."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02320-x","article-title":"Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)","volume":"17","author":"van Haalen FM","year":"2022","unstructured":"van Haalen FM, Kaya M, Pelsma IC, et al.. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet J Rare Dis. 2022, 17:178. 10.1186\/s13023-022-02320-x","journal-title":"Orphanet J Rare Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu M","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, et al.. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021, 9:847-75. 10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-023-00515-1","article-title":"Preventive strategies for hypercoagulation in Cushing's syndrome: when and how","volume":"21","author":"Lopes V","year":"2023","unstructured":"Lopes V, Marques O, De Sousa Lages A. Preventive strategies for hypercoagulation in Cushing's syndrome: when and how. Thromb J. 2023, 21:72. 10.1186\/s12959-023-00515-1","journal-title":"Thromb J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0600-y","article-title":"Perioperative thromboprophylaxis in Cushing's disease: what we did and what we are doing?","volume":"18","author":"Barbot M","year":"2015","unstructured":"Barbot M, Daidone V, Zilio M, et al.. Perioperative thromboprophylaxis in Cushing's disease: what we did and what we are doing?. Pituitary. 2015, 18:487-93. 10.1007\/s11102-014-0600-y","journal-title":"Pituitary"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad176","article-title":"High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery","volume":"190","author":"Isand K","year":"2024","unstructured":"Isand K, Feelders R, Brue T, et al.. High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery. Eur J Endocrinol. 2024, 190:75-85. 10.1093\/ejendo\/lvad176","journal-title":"Eur J Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0665-z","article-title":"A venous thromboembolism risk assessment model for patients with Cushing's syndrome","volume":"52","author":"Zilio M","year":"2016","unstructured":"Zilio M, Mazzai L, Sartori MT, et al.. A venous thromboembolism risk assessment model for patients with Cushing's syndrome. Endocrine. 2016, 52:322-32. 10.1007\/s12020-015-0665-z","journal-title":"Endocrine"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.02.050","article-title":"Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy","volume":"84","author":"Zaorsky NG","year":"2012","unstructured":"Zaorsky NG, Buyyounouski MK, Li T, Horwitz EM. Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy. Int J Radiat Oncol Biol Phys. 2012, 84:e13-7. 10.1016\/j.ijrobp.2012.02.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1999.91.2.0175","article-title":"Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease","volume":"91","author":"Semple PL","year":"1999","unstructured":"Semple PL, Laws ER Jr. Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease. J Neurosurg. 1999, 91:175-9. 10.3171\/jns.1999.91.2.0175","journal-title":"J Neurosurg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3171\/2014.10.FOCUS14705","article-title":"Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas","volume":"38","author":"Smith TR","year":"2015","unstructured":"Smith TR, Hulou MM, Huang KT, Nery B, de Moura SM, Cote DJ, Laws ER. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas. Neurosurg Focus. 2015, 38:E12. 10.3171\/2014.10.FOCUS14705","journal-title":"Neurosurg Focus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000150","article-title":"Does aspirin prevent venous thromboembolism?","volume":"2020","author":"Diep R","year":"2020","unstructured":"Diep R, Garcia D. Does aspirin prevent venous thromboembolism?. Hematology Am Soc Hematol Educ Program. 2020, 2020:634-41. 10.1182\/hematology.2020000150","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.ijp_732_21","article-title":"Aspirin for prophylaxis of VTE in patients with hip\/ knee replacement: systematic review and meta-analysis of non-randomized studies","volume":"56","author":"Maddukuri RK","year":"2024","unstructured":"Maddukuri RK, Chava H, Kondaveeti ST, Mutthineni MV, Vegesana BP. Aspirin for prophylaxis of VTE in patients with hip\/ knee replacement: systematic review and meta-analysis of non-randomized studies. Indian J Pharmacol. 2024, 56:420-9. 10.4103\/ijp.ijp_732_21","journal-title":"Indian J Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suae025","article-title":"Prevention of thromboembolism after a fracture: is aspirin enough?","volume":"26","author":"Spoladore R","year":"2024","unstructured":"Spoladore R, Milani M, Spreafico LP, Agnelli G, Savonitto S. Prevention of thromboembolism after a fracture: is aspirin enough?. Eur Heart J Suppl. 2024, 26:i102-7. 10.1093\/eurheartjsupp\/suae025","journal-title":"Eur Heart J Suppl"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-010645","article-title":"Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions","volume":"109","author":"Undas A","year":"2007","unstructured":"Undas A, Brummel-Ziedins KE, Mann KG. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood. 2007, 109:2285-92. 10.1182\/blood-2006-01-010645","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/371036-therapeutic-options-for-the-prevention-of-thromboses-in-cushings-syndrome-a-propensity-matched-retrospective-cohort-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T14:26:37Z","timestamp":1747923997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/371036-therapeutic-options-for-the-prevention-of-thromboses-in-cushings-syndrome-a-propensity-matched-retrospective-cohort-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.84616","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}